Trial intelligence / Profile preview

Lidocaine 2% versus articaine 4% for local anesthesia in children with MIH undergoing dental treatment

MOH_2026-01-12_015596Phase 3Completed

Sponsor
ד"ר סואר חלבי
Start
Aug 2025
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, single-blind trial of lidocaine, articaine and nitrous oxide in molar incisor hypomineralisation (MIH) (2 arms), sponsored by ד"ר סואר חלבי. Primary endpoint: Anesthetic efficacy. Started Aug 2025; status: completed.

02

Drugs

lidocainearticainenitrous oxide
03

Conditions

molar incisor hypomineralisation (MIH)

Beyond the preview

Go deeper on MOH_2026-01-12_015596.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on MOH_2026-01-12_015596.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call